Chief Medical Officer

Chief Scientific Officer

Transcript : Revolution Medicines, Inc. - Special Call

Iambic to Present New Pre-Clinical NSCLC Data for IAM1363, a Selective Type II Inhibitor for HER2 Cancers, at the 2025 World Conference on Lung Cancer

Iambic to Participate in September Investor Conferences

Appointments and advancements for Aug. 6, 2025

Software Engineer II/Senior Software Engineer (Backend)

Iambic Therapeutics is a clinical-stage life-science and technology company focused on developing novel medicines using AI-driven discovery and development platforms. They are seeking a talented Software Engineer II/Senior Software Engineer to contribute to the backend server development of their Drug Discovery platform, collaborating with cross-functional teams and supporting the drug discovery process.

Sign up with Google

Sign in with Google